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Oximetry using multispectral imaging: theory and application 1 
Lewis E. MacKenzie1, Andrew R Harvey2 2 
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DL1 3LE. 4 
2. School of Physics and Astronomy, College of Science and Engineering, University 5 
of Glasgow, UK. G12 8QQ.  6 
 7 
E-mail: Lewis.E.MacKenzie@Durham.ac.uk 8 
 9 
Abstract. Multispectral imaging (MSI) is widely applied across various imaging modalities as 10 
a technique for measurement of blood oxygen saturation (OS) in vivo, consequently providing 11 
new information about physiology and disease development. This tutorial aims to provide a 12 
thorough introduction to the theory and application of MSI oximetry for researchers new to the 13 
field, whilst also providing detailed information for more experienced researchers. The optical 14 
theory underlying two-wavelength oximetry, three-wavelength oximetry, pulse oximetry, and 15 
multispectral oximetry algorithms are described in detail. The varied challenges of applying MSI 16 
oximetry to in vivo applications are outlined and discussed, covering: the optical properties of 17 
blood and tissue, optical paths in blood vessels, tissue auto-fluorescence, oxygen diffusion, and 18 
common oximetry artefacts. Essential image processing techniques for MSI are discussed, in 19 
particular, image acquisition, image registration strategies, and blood vessel line profile fitting. 20 
Calibration and validation strategies for MSI are discussed, including comparison techniques, 21 
physiological interventions, and phantoms. The optical principles and unique imaging 22 
capabilities of various cutting-edge MSI oximetry techniques are discussed, including 23 
photoacoustic imaging, spectroscopic optical coherence tomography, and snapshot MSI.  24 
Page 1 of 43 AUTHOR SUBMITTED MANUSCRIPT - JOPT-104791.R2
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60 Ac
ce
pte
d 
an
us
cri
pt
 
 
2 
 
2 
 
Contents 1 
1. Introduction  2 
1.1 The application and utility of multispectral imaging oximetry ----------------------------------- 3 3 
1.2 The principle of optical oximetry --------------------------------------------------------------------- 3 4 
1.3 Milestones in the development of MSI oximetry technology ------------------------------------- 5 5 
2. Theory of oximetry  6 
2.1 Two wavelength oximetry ----------------------------------------------------------------------------- 6  7 
2.2 Pulse oximetry ------------------------------------------------------------------------------------------- 9 8 
2.3 Three-wavelength oximetry -------------------------------------------------------------------------- 10 9 
2.4 Multispectral oximetry -------------------------------------------------------------------------------- 11 10 
3. Challenges for in vivo multispectral imaging oximetry 11 
3.1 Optical absorption by haemoglobin variants and blood plasma ---------------------------------- 14 12 
3.2 Pigmentation in tissue --------------------------------------------------------------------------------- 15 13 
3.3 Optical scattering by tissue ---------------------------------------------------------------------------- 15 14 
3.4 Other challenges of imaging through tissue -------------------------------------------------------- 16 15 
3.5 Scattering by blood ------------------------------------------------------------------------------------ 17 16 
3.6 Mitigating specular reflections from blood vessels ------------------------------------------------ 18 17 
3.7 Optical paths through blood vessels ----------------------------------------------------------------- 19 18 
3.8 Rattlesnake artefacts ----------------------------------------------------------------------------------- 20 19 
3.9 Oxygen diffusion --------------------------------------------------------------------------------------- 20 20 
3.10 Multi-OS laminar flow in trunk veins ------------------------------------------------------------- 22 21 
4. Image processing for multispectral imaging oximetry 22 
4.1 Image acquisition --------------------------------------------------------------------------------------  22 23 
4.2 Co-registration of multispectral images ------------------------------------------------------------- 23 24 
4.3 Estimating the Transmission of blood vessels ----------------------------------------------------- 25 25 
5. Strategies for validation of multispectral imaging oximetry  26 
5.1 Testing fundamental optical assumptions: Monte Carlo simulations ---------------------------- 26 27 
5.2 Validation with artificial phantoms ------------------------------------------------------------------ 27 28 
5.3 In vivo validation strategies --------------------------------------------------------------------------- 27 29 
6. Multispectral oximetry imaging modalities  30 
6.1 Time-sequential multispectral imaging ------------------------------------------------------------- 29 31 
6.2 Snapshot multispectral imaging oximetry ---------------------------------------------------------- 29 32 
6.3 Scanning laser ophthalmoscopes --------------------------------------------------------------------- 30 33 
6.4 Photoacoustic imaging -------------------------------------------------------------------------------- 30 34 
6.5 Spectroscopic Optical Coherence Tomography ---------------------------------------------------- 31 35 
6.6 Dual-wavelength photothermal optical -------------------------------------------------------------- 31 36 
7. Summary and Conclusions ----------------------------------------------------------------------------- 31  37 
Page 2 of 43AUTHOR SUBMITTED MANUSCRIPT - JOPT-104791.R2
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60 Ac
ce
pte
d 
an
us
cri
pt
 
 
3 
 
3 
 
1. Introduction 1 
1.1. The application and utility of multispectral imaging oximetry 2 
Highly localized measurement of blood oxygen saturation (OS) within tissue is useful for establishing 3 
physiological norms, and for monitoring hyperoxia (i.e. elevated OS) and hypoxia (i.e. reduced OS); 4 
which can be cause or symptom of various diseases. For example, hyperoxia is associated with 5 
retinopathy of prematurity[1]; arterial occlusion induces hypoxia, with subsequent loss of tissue 6 
function[2]; and cancerous tumours can cause localized hypoxia due to excessive metabolic 7 
demand.[3,4] However, many commonly used oximetry techniques, including blood gas measurement 8 
and pulse oximetry, lack the spatial resolution or tissue specificity required to measure blood OS in a 9 
manner relevant for detail studies of physiology or disease development. Multispectral imaging (MSI) 10 
oximetry is an optical technique that utilises the OS-dependent absorption spectra of haemoglobin within 11 
blood to quantify OS with high spatial and temporal resolution. This makes MSI oximetry ideal for 12 
highly specific studies of  OS in small blood vessels that supply tissue.[5]  13 
MSI oximetry can be applied with various imaging techniques to image blood vessels in different bodily 14 
tissues. For example, MSI retinal fundus cameras are utilized for measuring blood oxygen in the eye[6], 15 
and MSI microscopes can be used to measure oxygen within individual red blood cells.[5] Emerging 16 
imaging modalities such as photoacoustic tomography (PAT) and spectroscopic optical coherence 17 
tomography (S-OCT) have also been utilized to provide enhanced oximetry imaging capabilities: PAT 18 
enables oximetry in deep tissue, and S-OCT provides simultaneous 3D mapping of both tissue and OS 19 
(see Section 6).  20 
MSI oximetry has been applied to diverse applications in vivo, including measurement of blood OS in 21 
the spinal cord,[7] the brain,[8] muscle tendons,[9,10] the bowel,[11] the oral microvasculature,[12]  22 
and the skin.[13] In the eye, MSI oximetry has established the oxygen dynamics and physiological 23 
norms of the retina,[6] the choroid,[14] the bulbar conjunctiva,[15] and the episcleral blood vessels.[15]  24 
Various diseases have been studied with MSI oximetry, including diabetic retinopathy,[16,17] 25 
glaucoma,[18–20] retinal vessel occlusion,[2,6] stroke,[8] rheumatoid arthritis,[10] diabetic foot 26 
ulcers,[13,21] and cancerous tumor development.[3,22] For the full applications of oximetry to the 27 
monitoring of retinal disease, readers are referred to recent reviews.[6,23,24] 28 
1.2. The principle of optical oximetry 29 
 30 
The theory of MSI oximetry is fundamentally the same across all imaging techniques, in that all MSI 31 
modalities measure the OS-dependent absorption of light by haemoglobin (see Figure 1). Haemoglobin 32 
is the dominant absorber of light in blood, with typically ~250 million haemoglobin molecules inside a 33 
normal red blood cell  (RBC).[25] The function of haemoglobin is to transport oxygen around the body 34 
by reversible binding of oxygen to four heme sub-units. These heme units strongly absorb blue and 35 
green light, giving haemoglobin its distinctive red colour.* When oxygen binds or unbinds to 36 
haemoglobin, the optical absorbance properties of haemoglobin are altered, resulting in a change in the 37 
optical absorption spectra of blood (see Figure 1).† The affinity of haemoglobin for oxygen is described 38 
by the sigmoid-shaped oxygen dissociation curve, which varies with temperature and pH, as well as 39 
between species.[26] Each haemoglobin molecule can bind up to four oxygen molecules: one to each 40 
                                                     
* Note that contrary to popular belief, deoxygenated blood is not blue. The blue appearance of veins through skin 
tissue is due to the combination of multiple effects, including optical scattering and absorption by tissue, 
combined with quirks of human  visual perception.[159] 
† The change in optical absorbance of haemoglobin as oxygen binds or unbinds is due to a change in electron 
configuration of haemoglobin. 
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heme group – resulting in five possible states for each individual haemoglobin molecule: 0%, 25%, 1 
50%, 75%, and 100% oxygen occupancy. A population of many haemoglobin molecules can be of an 2 
average OS anywhere between 0 – 100% OS. 3 
The OS of blood is defined as: 4  l p=Z=𝐶𝐶𝑂𝑂2𝐻𝐻𝐻𝐻𝐶𝐶𝐻𝐻𝐻𝐻𝐻𝐻 =  𝐶𝐶𝑂𝑂2𝐻𝐻𝐻𝐻𝐶𝐶𝑂𝑂2𝐻𝐻𝐻𝐻+ 𝐶𝐶𝐻𝐻𝐻𝐻 , 1 
Where 𝐶𝐶𝐻𝐻𝐻𝐻𝐻𝐻, 𝐶𝐶𝑂𝑂2𝐻𝐻𝐻𝐻, and 𝐶𝐶𝐻𝐻𝐻𝐻 are, respectively, the molar concentrations of total haemoglobin, fully 5 
oxygenated haemoglobin, and fully deoxygenated haemoglobin. For typical arteries (i.e. blood vessels 6 
carrying oxygenated blood away from the heart), nominal OS is in the range 94 - 98%, corresponding 7 
to a partial pressure of oxygen (pO2) of ~ 100 mmHg. In typical veins (i.e. deoxygenated blood vessels 8 
carrying blood towards the heart), nominal OS is ~70%, corresponding to a  pO2 ~ 40 mmHg.[27] 9 
However, OS values within the body vary considerably, depending on parameters, such as the 10 
atmospheric partial pressure of oxygen (pO2), blood flow velocity, and metabolic demand by tissue. For 11 
example, the metabolic demand for oxygen in retinal tissue is particularly high, resulting in venous OS 12 
~60%.[28] 13 
The absorption spectra of fully oxygenated haemoglobin (O2Hb) and fully deoxygenated haemoglobin 14 
(Hb) are shown in Figure 1. The spectra exhibit several isobestic wavelengths, at which the extinction 15 
coefficients of haemoglobin are insensitive to changes in OS, interspersed with spectral bands where the 16 
extinction coefficients vary strongly with OS. Two-wavelength oximetry, a simple approach to 17 
oximetry, exploits the approximately linear relationship between OS and the ratio of measured optical-18 
density at an isobestic waveband to the optical-density at an OS-sensitive waveband. The strength of 19 
such a ratiometric technique arises from the simplicity of application: however, the assumption of 20 
linearity, based on the Beer-Lambert law, is an over-simplification, where presence of optical scattering 21 
and additional chromophores in neighboring tissue, or indeed other species of Hb within the blood, can 22 
lead to inaccuracies.[29] The use of multispectral imaging with various degrees of sophistication and 23 
complexity provides scope for increased accuracy and robustness in oximetry. Simply put, recording the 24 
absorption of blood at more wavelengths enables more unknown parameters to be accounted for, 25 
improving oximetry (see Section 2.4). 26 
 27 
Page 4 of 43AUTHOR SUBMITTED MANUSCRIPT - JOPT-104791.R2
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60 Ac
ce
pte
d M
nu
sc
ipt
 
 
5 
 
5 
 
 
Figure 1. The optical absorption spectra of oxygenated haemoglobin 
(HbO2)[the red line] and deoxygenated haemoglobin (Hb)[the blue line]. 
Figure created from spectroscopic data tabulated by S. Prahl (1999).[30] The 
units for extinction coefficient are per centimetre per mole (cm-1 M-1). 
1.3. Milestones in the development of MSI oximetry technology 1 
 2 
The pioneering MSI oximetry studies of retinal OS were undertaken in the 1960s, establishing the 3 
fundamental principles of two-wavelength oximetry upon which all subsequent research has been 4 
built.[31–33] Initially, retinal oximetry was calibrated by ex vivo blood gas measurement. However, the 5 
advent of fingertip pulse oximetry subsequently enabled simpler calibration by non-invasive 6 
measurement of arterial OS via the fingertip (see Section 2.2).[34] Later oximetry studies advanced the 7 
field by establishing techniques such as three-wavelength oximetry,[35] scanning laser retinal MSI,[36] 8 
and high spectral resolution retinal spectrophotometry.[37,38] For more detailed information on the 9 
development of retinal oximetry, the reader is referred to the 2014 retrospective by Jim Beach.[24]  10 
In the late 1990s, digital imaging technology began to replace photographic cameras, paving the way 11 
for automated computational analysis of images.[24,39] The mid-to-late 2000s saw the development of 12 
two commercially available retinal oximetry systems; the Oxymap T1 retinal oximeter (Oxymap ehf, 13 
Iceland) [40] and the Imedos retinal oximeter (Imedos Systems UG, Germany).[17] Advances in 14 
computational power and techniques enabled automatic oximetry, consequently enabling the study of 15 
numerous retinal diseases by ophthalmologists.[23]  16 
In the past decade, emerging imaging modalities have enabled MSI oximetry to be applied to 17 
increasingly diverse in vivo applications. Snapshot MSI systems have enabled oximetry with sub-second 18 
temporal resolution, enabling observations of fast biological processes such as oxygen diffusion into the 19 
microvasculature [15] and MSI endoscopes have provided measurements in tissue that are not accessible 20 
with traditional imaging techniques, e.g. within the bowel.[11] Photoacoustic techniques have enabled 21 
deep-tissue oximetry of the brain, cancer tumors, and entire small animals,[41] and spectroscopic optical 22 
coherence tomography (S-OCT) has enabled complimentary 3D mapping of OS and tissue structure.[42] 23 
Across all MSI modalities, advancement and application of MSI oximetry technology has yielded 24 
considerable insights into physiological norms and disease development.[6] Section 6 provides further 25 
details on the applications and optical principles underpinning these emerging MSI modalities. 26 
2. Theory of oximetry 27 
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2.1. Two-wavelength oximetry 1 
2.1.1. Derivation of two-wavelength oximetry 2 
The simplest and most commonly used form of oximetry is two-wavelength oximetry, which is based 3 
on the Beer-Lambert law of light transmission through a medium: 4 
  Iλ = Iλo exp (−𝑐𝑐ελ d) 2 
where=fﺻ is the intensity of the light transmitted through the medium, =fﺻç  is the intensity of the light 5 
incident upon blood,  is the molar concentration of absorbers (i.e. haemoglobin) within blood [M], شﺻ 6 
is the wavelength-dependent molar extinction coefficient of haemoglobin [cm-1M-1], and d is the optical 7 
path length of light through the blood [cm]. For blood, ελ, is defined by: 8 
 𝜀𝜀𝜆𝜆=Z=�𝑂𝑂𝑂𝑂  𝜀𝜀𝜆𝜆𝑂𝑂2𝐻𝐻𝐻𝐻�H�EN J OSF 𝜀𝜀𝜆𝜆𝐻𝐻𝐻𝐻�, 3 
where OS is the fractional blood oxygen saturation (range 0-1), ελO2Hb is the molar extinction 9 
coefficient of fully oxygenated haemoglobin, and ελHb is the molar extinction coefficient of 10 
deoxygenated haemoglobin. No other chromophores are included in this simplified model. The 11 
transmission, T𝜆𝜆, of the blood is defined as: 12 
 𝑇𝑇𝜆𝜆 = � 𝐼𝐼λ𝐼𝐼λo�. 4 
The optical-density (OD) of the blood at a given wavelength, ODﺻ, is then defined as: 13 
 𝑂𝑂𝑂𝑂Ƌ     = c d=ƅƋ . 5 
Assuming that c and d are identical at both wavelengths, then the optical-density ratio, ODR, is: 14 
 𝑂𝑂𝑂𝑂𝑅𝑅 = 𝑂𝑂𝑂𝑂ƋN
𝑂𝑂𝑂𝑂ƋO
 = 𝑐𝑐 𝑑𝑑 𝜀𝜀𝜆𝜆1
𝑐𝑐 𝑑𝑑 𝜀𝜀𝜆𝜆2 = 𝜀𝜀𝜆𝜆1𝜀𝜀𝜆𝜆2 . 6 
If one wavelength is chosen to be isobestic, i.e. insensitive to changes in OS, and the other wavelength 15 
is chosen to be sensitive to changes in OS, then ODR will be linearly proportional to OS.[31] If nominal 16 
OS values are known by independent means, then ODR can be empirically calibrated to OS by fitting 17 
ODR to the equation of a straight line, i.e.: 18 
 𝑂𝑂𝑂𝑂 = 𝑎𝑎 ∗ 𝑂𝑂𝑂𝑂𝑅𝑅 + 𝑏𝑏, 7 
where a and b are empirically derived calibration coefficients obtained by plotting ODR vs. OS. Thus, 19 
from measuring transmission at two wavelengths, ODR can be calculated, from which OS can be 20 
estimated by empirical calibration.  21 
2.1.2. Optimal vessel transmission and wavelength combinations for two-wavelength oximetry 22 
For accurate oximetry, blood vessels must neither be too transparent nor too opaque. Based upon work 23 
by Assendelft (1970),[43] Smith derived the following optimal transmission for a blood vessel in order 24 
to minimize sensitivity of OS to transmission measurement uncertainty/error.[44] Smith’s derivation 25 
starts from the definition of optical-density, ODﺻ: 26 
 𝑂𝑂𝑂𝑂λ = − 𝑙𝑙𝑙𝑙𝑙𝑙  (𝑇𝑇λ) =  𝑙𝑙𝑙𝑙(𝑇𝑇λ)𝑙𝑙𝑙𝑙(10). 8 
The absolute error function for ODλ is then found by differentiating: 27 
 𝛥𝛥𝑂𝑂𝑂𝑂λ = 𝑑𝑑𝑂𝑂𝑂𝑂λ𝑑𝑑𝐻𝐻λ 𝛥𝛥𝑇𝑇λ =  𝛥𝛥𝐻𝐻λ𝑙𝑙𝑙𝑙 (10) 1𝐻𝐻λ . 9 
The fractional error function of ODλ is then: 28 
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𝛥𝛥𝑂𝑂𝑂𝑂λ
𝑂𝑂𝑂𝑂λ
= 𝛥𝛥𝑇𝑇λ
𝑇𝑇λ𝑙𝑙𝑙𝑙(𝑇𝑇λ) .      10 
To minimise the relative error of ODλ, the first derivative, with respect to 𝑇𝑇λ, of Equation 10 must be 1 
found, and then set to zero. 2 
 
𝑑𝑑(𝛥𝛥𝑂𝑂𝑂𝑂λ/𝑂𝑂𝑂𝑂λ)
𝑑𝑑𝑇𝑇λ
= 𝑙𝑙𝑙𝑙 (𝑇𝑇λ) + 1[𝑇𝑇λ 𝑙𝑙𝑙𝑙(𝑇𝑇λ)]2  𝛥𝛥𝑇𝑇λ = 0 .   11 
Discarding the non-physical solution of Tﺻ= 0, leaves the following solution: 3 
 
𝑙𝑙𝑙𝑙(𝑇𝑇λ) + 1 = 0, 
=> 𝑇𝑇λ = 1/e = 36.8%, 
=> 𝑂𝑂𝑂𝑂λ= 0.434. 
 12 
This solution indicates that transmission of 36.8% or an OD = 0.434 will be optimal for minimizing 4 
errors due to uncertainties in transmission in two-wavelength oximetry. Expanding this further, Smith 5 
showed that the transmission range between 10% and 70% is broadly optimal for oximetry; outside this 6 
transmission range, the error function associated with measurement errors grows rapidly, so accurate 7 
oximetry becomes untenable.[44] 8 
In the same study, Smith (1999) theoretically investigated the noise-sensitivity of various waveband 9 
combinations for two-wavelength oximetry, concluding that optimal waveband combinations for retinal 10 
oximetry would be 635 nm & 965 nm as well as 488 nm & 635 nm.[44] However, these theoretical 11 
waveband combinations may not be practical because they do not take into account the practical 12 
constraints of available light sources, tissue irradiance limits, pigmentation, and tissue scattering 13 
properties.  14 
In practice, the optimal-wavelength combination for a given application is dictated by the calibre of 15 
blood vessels being investigated, potential sources of confounding absorption by tissue, and the 16 
constraints of the illumination and imaging systems. For two-wavelength retinal oximetry, the 17 
wavelength combination of wavebands ~600 nm (OS sensitive) and ~570 nm (isobestic) has been widely 18 
adopted. Calculated transmissions at several wavelengths of blood vessels of a range of calibers 19 
containing fully and partially oxygenated blood are shown in Figure 2. Scattering is neglected and the 20 
wavelength and caliber ranges for accurate oximetry are highlighted. 21 
 22 
 23 
Figure 2. Calculated single-pass transmissions for blood vessels at various wavebands assuming 24 
single-pass transmission and the concentration of haemoglobin to be 20 mM. (A) 100% OS, (B) 25 
70% OS. No other chromophores or optical scattering was modelled. 26 
2.1.3. Corrections for blood vessel diameter and tissue pigmentation in two-wavelength oximetry 27 
 28 
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Hickam et al. (1963) noted that the observed ODR of a blood vessel is dependent on the diameter of that 1 
blood vessel.[32] Exemplar experimental data verifying this effect shown in Figure 3. It is thought that 2 
this ODR diameter-dependence is due to scattering of light and other terms which are not incorporated 3 
in the normal Beer-Lambert law, and thus not included in the theory of two-wavelength oximetry.[45] 4 
The resultant ODR offset between blood vessels of different diameters is of particular importance in 5 
experiments where blood vessels change in diameter (i.e. if the vessels dilate or contract). Stimuli such 6 
as hypoxia, hyperoxia, and, in the retina, flicker-light stimulation can cause such responses (see Section 7 
5.3.3), and thus potentially introduce changes in ODR that are not due to changes in OS alone.  8 
 9 
This vessel diameter-dependent effect is also problematic for oximetry of veins, which are typically 10 
larger than arteries; this can lead to a spurious decrease in venous OS estimated by two-wavelength 11 
oximetry. To compensate for this, Hammer et al., (2008) implemented an empirically-derived size-12 
dependent venous OS correction factor.[29] A similar calibration issue is associated with tissue 13 
pigmentation: in two-wavelength oximetry, venous OS can spuriously appear to increase with increasing 14 
retinal pigmentation. Again, Hammer et al., (2008) implemented an empirically-derived, pigmentation-15 
dependent, venous OS-correction factor to compensate for this effect.[29]  16 
 17 
 18 
 19 
 
Figure 3.  ODR vs. OS for fluorinated ethylene propylene 
(FEP) capillaries filled with ex vivo heparinised equine 
blood. The 150 µm capillary has a greater baseline ODR than 
the 100 µm capillary, but change in ODR for a given change 
in OS is approximately the same for both (fitted lines). 
Equipment used: FEP capillaries imaged with a retinal 
fundus camera modified with a snapshot multispectral 
imaging system. OS of ex vivo equine blood verified by an 
optical blood gas analyser [GEM OPL, Instrumentation 
Laboratories] with a quoted OS uncertainty of ± 1.8% (not 
depicted). OS of blood was varied by addition of sodium 
dithionite.[46] Vertical error bars show the standard 
deviation of ODR along the length of the capillary section 
analysed. 
 20 
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2.2. Pulse oximetry 1 
Pulse oximetry is widely used to non-invasively monitor arterial OS via the fingertip. Pulse oximetry 2 
uses the varying optical absorption due to pulsatile arterial blood to remove the influence of background 3 
absorbance by tissue and venous blood (assumed to be non-pulsatile); in this manner, pulse oximetry is 4 
similar to photoplethysmography.[47] Yet, by calculating the ODR of the pulsating absorbance 5 
component, two-wavelength oximetry can then be applied to estimate peripheral arterial OS.[34] To 6 
enable measurement through relatively thick tissue (i.e. in the range of one to five centimeters) pulse 7 
oximeters typically use wavelengths which are minimally absorbed and scattered by blood or tissue, e.g. 8 
650 nm and 800 nm. Pulse oximeters are calibrated across many subjects by relating average ODR to 9 
average arterial OS, as measured by an ex vivo blood-gas analyzer. In humans, pulse oximeters are not 10 
calibrated for OS < 80% due to ethical constraints,[48,49] and generally have an uncertainty quoted at 11 
± 2%.[50] Pulse oximeters for animal use may, however, be calibrated for lower oxygen saturations due 12 
to less stringent ethical constraints. 13 
In adult humans, the fingertip is the usual location for monitoring arterial OS, but pulse oximetry 14 
measurements can also be made via the earlobe[51] and the big toe.[52] In infants, being smaller than 15 
adults, pulse oximetry measurements can be made via alternative tissue beds, including via the palm of 16 
the hand, the sole of the foot, and the scrotum.[53,54] However, it should be noted that pulse oximeter 17 
manufacturers typically do not provide calibration for non-fingertip applications. The reliability of pulse 18 
oximeters can be reduced by low blood flow, caused by factors such as pressure on the measurement 19 
tissue, or by cold temperatures. As an example, the earlobe is particularly sensitive to reduced blood 20 
flow due to the pressure of clip-on pulse oximeters.[51] Additionally, diseases that affect the optical 21 
properties of blood, e.g. sickle cell anemia, may interfere with pulse oximetry.[55] Further, commercial 22 
pulse oximeters are often ‘black box’ devices with non-optional features such as time-integrated signal 23 
averaging to reduce noise in measurement. Consequently, when using pulse oximetry as a reference for 24 
MSI oximetry, the limitations of both the equipment, and the physiology of the subject should be 25 
carefully considered to ensure a relevant comparison. 26 
2.3. Three-wavelength oximetry 27 
2.3.1. Derivation of three-wavelength oximetry 28 
Three-wavelength oximetry was developed by Pittman and Duling in 1975, and advanced the field of 29 
oximetry by incorporating optical scattering parameters into the optical transmission models of 30 
blood.[35] The technique requires three wavebands, proximal to each other in the haemoglobin 31 
absorption spectrum: two isobestic wavelengths are used to estimate the contribution by optical 32 
scattering, and a third wavelength is used for OS sensitivity.  33 
The derivation of the three-wavelength oximetry model starts with the modified Beer-Lambert law: 34 
 𝑂𝑂𝑂𝑂𝜆𝜆 =  𝜀𝜀𝜆𝜆 𝑐𝑐 𝑑𝑑 + 𝐵𝐵𝜆𝜆, 13 
where Bλ is a term describing the effect of scattering on optical density. For two proximal wavelengths,  35 
λ1 and λ2, 𝐵𝐵λ will be approximately equal for both, i.e.: 36 
 𝐵𝐵𝜆𝜆1 = 𝐵𝐵𝜆𝜆2 =  𝐵𝐵, 14 
  𝑂𝑂𝑂𝑂𝜆𝜆1 =  𝜀𝜀𝜆𝜆1 𝑐𝑐 𝑑𝑑 +  𝐵𝐵, 15 
  𝑂𝑂𝑂𝑂𝜆𝜆2 =  𝜀𝜀𝜆𝜆2 𝑐𝑐 𝑑𝑑 +  𝐵𝐵. 16 
Solving Equations 15 and 16 simultaneously yields: 37 
 𝐵𝐵 = (𝜀𝜀𝜆𝜆1/𝜀𝜀𝜆𝜆2) 𝑂𝑂𝑂𝑂𝜆𝜆1 −  𝑂𝑂𝑂𝑂𝜆𝜆2 (𝜀𝜀𝜆𝜆1/𝜀𝜀𝜆𝜆2) − 1 . 17 
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It should be noted here, that if the term of (ελ1/ελ2) tends to 1, then minor errors in the measurement 1 
of OD will result in large errors in the estimation of 𝐵𝐵.[44] However, assuming the value of 𝐵𝐵 is 2 
estimated accurately, then it can be incorporated into Equation 7 to yield: 3 
 𝑂𝑂𝑂𝑂 = 𝑎𝑎 � 𝑂𝑂𝑂𝑂𝜆𝜆3+𝐵𝐵 
𝑂𝑂𝑂𝑂𝜆𝜆𝑟𝑟𝑟𝑟𝑟𝑟+𝐵𝐵
� +  𝑏𝑏, 18 
Where 𝑂𝑂𝑂𝑂𝜆𝜆3 is the optical-density at a third, oxygen-sensitive, wavelength; 𝑂𝑂𝑂𝑂𝜆𝜆𝜆𝜆𝜆𝜆𝜆𝜆 is the optical-density 4 
at one of the isobestic wavelengths; and 𝑎𝑎 and 𝑏𝑏 are empirically derived calibration coefficients. 5 
Equation 18 has the form of the equation of a straight line, so the OD ratio can be calibrated to OS in a 6 
manner similar to two-wavelength oximetry, i.e. by plotting at least two known OS reference points 7 
versus the product of the right side of Equation 18.[35] 8 
2.3.2. Discussion, and the application of, three-wavelength oximetry  9 
 10 
Three-wavelength oximetry is somewhat limited in that it is only applicable for waveband triads that 11 
exhibit near-identical scattering properties, somewhat similar absorption properties, whilst including 12 
two isobestic wavebands and one OS-dependent contrast waveband. For example, Pittman and Duling 13 
(1975)[35] found that blue wavelengths  (420 – 450 nm) are particularly susceptible to spurious errors 14 
in the estimation of the parameter 𝐵𝐵, due to the large variations of 𝜀𝜀𝜆𝜆, and thus large variations of 15 
refractive index, across this waveband. Instead, Pittman and Duling employed the more favourable 16 
wavelength triad of 520 nm, 546 nm, and 555 nm, reporting ± 1% OS uncertainty for ex vivo blood 17 
samples.[35]  18 
Smith (1999)[44] suggested the following wavelength triads as theoretically optimal for three-19 
wavelength oximetry of retinal blood vessels: (1) 488 nm, 635 nm, and 905 nm; (2) 600 nm, 635 nm, 20 
and 905 nm; (3) 635 nm, 720 nm, and 905 nm. Whilst three-wavelength oximetry may offer improved 21 
accuracy over two-wavelength oximetry by accounting for scattering, three-wavelength oximetry still 22 
requires calibration of ODR to blood of known OS, and the choice of potential imaging wavebands is 23 
rather limited. As such, three-wavelength oximetry has been largely superseded by multispectral 24 
oximetry algorithms (see Section 2.4). 25 
2.4. Multispectral oximetry  26 
2.4.1. Theory and derivation of multispectral oximetry algorithms 27 
Multispectral and hyperspectral‡ oximetry algorithms estimate OS by computationally fitting 28 
experimentally determined blood vessel transmission values to a theoretical optical model incorporating 29 
OS and other optical parameters, e.g. to model the effects of optical scattering or background 30 
pigmentation. Unlike two- and three-wavelength oximetry, this optical model approach enables 31 
multispectral oximetry algorithms to be applied without implicit empirical calibration; however, 32 
validation of oximetry is a key challenge for applying multispectral oximetry (see Section 2.4.2). 33 
The parameters included in multispectral oximetry models vary between studies; some parameters are 34 
“hard-wired”, and some are estimated from the recovered fit to a transmission profile. Table 1 provides 35 
a summary of hard-wired and recovered parameters in published multispectral oximetry models. As a 36 
minimum,  multispectral oximetry models will “hard-wire” in the OS-dependent extinction coefficients 37 
of haemoglobin, 𝜀𝜀𝜆𝜆𝑂𝑂2𝐻𝐻𝐻𝐻 and 𝜀𝜀𝜆𝜆𝐻𝐻𝐻𝐻. Further terms may be added to account for various other parameters, 38 
including concentration of haemoglobin, blood-vessel diameter, optical-path through a blood vessel (see 39 
                                                     
‡ There is no formal definition of multispectral or hyperspectral imaging. Both techniques follow the same 
principle, but multispectral imaging typically incorporates fewer than ten wavebands, often non-continuous, and 
hyperspectral imaging can incorporate several tens or hundreds of contiguous wavebands (see Table 1 for 
examples). For simplicity, we will refer primarily to multispectral imaging in this paper. 
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Section 3.7), optical back scatter by blood, pigmentation of surrounding tissue, and contrast reduction 1 
due to overlying tissue and scattering by the ocular media. As a general rule, the maximum number of 2 
parameters that can be estimated to a model cannot be greater than the number of independent 3 
measurements incorporated in the model,§ thus the more parameters that are modelled, the more 4 
wavelengths are required to apply the model. A summary of multispectral oximetry models reported in 5 
the literature, and the optical parameters they include, is provided in Table 1. 6 
 7 
van der Putten et al. (2017) reported the most sophisticated multispectral oximetry model to date.[7] 8 
Their model builds upon the thoroughly validated model developed by Smith et al., (2000), which is 9 
applied to directly imaged blood vessels.[56] The derivation of their model starts with the Beer Lambert 10 
law:  11 
 𝑂𝑂𝑂𝑂𝜆𝜆 = 𝑙𝑙𝑙𝑙𝑙𝑙10(𝑇𝑇λ) =  𝜀𝜀𝜆𝜆 𝐶𝐶𝐻𝐻𝐻𝐻𝐻𝐻 𝑑𝑑, 19 
where 𝐶𝐶𝐻𝐻𝐻𝐻𝐻𝐻 is the total molar concentration of haemoglobin. From Equation 1,  𝐶𝐶𝐻𝐻𝐻𝐻𝐻𝐻 =  𝐶𝐶𝑂𝑂2𝐻𝐻𝐻𝐻 + 𝐶𝐶𝐻𝐻𝐻𝐻, 12 
so 𝑂𝑂𝑂𝑂𝜆𝜆 can be written as: 13 
 𝑂𝑂𝑂𝑂𝜆𝜆 = 𝜀𝜀𝜆𝜆𝑂𝑂2𝐻𝐻𝐻𝐻 𝐶𝐶𝑂𝑂2𝐻𝐻𝐻𝐻 𝑑𝑑 + 𝜀𝜀𝜆𝜆𝐻𝐻𝐻𝐻𝐶𝐶𝐻𝐻𝐻𝐻𝑑𝑑, 20 
Rearranging gives: 14 
 𝑂𝑂𝑂𝑂𝜆𝜆 = 𝐶𝐶𝐻𝐻𝐻𝐻𝐻𝐻𝑑𝑑��𝜀𝜀𝜆𝜆𝑂𝑂2𝐻𝐻𝐻𝐻 −  𝜀𝜀𝜆𝜆𝐻𝐻𝐻𝐻�𝑂𝑂𝑂𝑂 +  𝜀𝜀𝜆𝜆𝐻𝐻𝐻𝐻�. 21 
To this, an additive reduced scattering coefficient  µλ
′  (measured by Faber et al., (2004)[57]) is added 15 
to account for scattering of light by red blood cells. This gives: 16 
 𝑂𝑂𝑂𝑂𝜆𝜆 = 𝐶𝐶𝐻𝐻𝐻𝐻𝐻𝐻𝑑𝑑��𝜀𝜀𝜆𝜆𝑂𝑂2𝐻𝐻𝐻𝐻 −  𝜀𝜀𝜆𝜆𝐻𝐻𝐻𝐻�𝑂𝑂𝑂𝑂 + 𝜀𝜀𝜆𝜆𝐻𝐻𝐻𝐻�+µ𝜆𝜆′ 𝑑𝑑. 22 
The contribution of single- and double-pass light paths through a blood vessel [58] can be accounted for 17 
by adding two multiplicative factors, 𝛼𝛼 and 𝛽𝛽, representing the fraction of light rays that undergo single-18 
or double-pass transmission respectively (see Section 3.7). Additionally, 𝑂𝑂𝑂𝑂𝜆𝜆 can be related to 19 
transmission by 𝑇𝑇λ = 10−𝑂𝑂𝑂𝑂𝜆𝜆. Therefore, Equation 22 can be rewritten as:  20 
 
𝑇𝑇λ = �𝛼𝛼 10−�𝐶𝐶𝐻𝐻𝐻𝐻𝐻𝐻 𝑑𝑑��𝜀𝜀𝜆𝜆𝑂𝑂2𝐻𝐻𝐻𝐻− 𝜀𝜀𝜆𝜆𝐻𝐻𝐻𝐻�𝑂𝑂𝑂𝑂+ 𝜀𝜀𝜆𝜆𝐻𝐻𝐻𝐻�+µ𝜆𝜆′ 𝑑𝑑� +
𝛽𝛽10−�2𝐶𝐶𝐻𝐻𝐻𝐻𝐻𝐻 𝑑𝑑��𝜀𝜀𝜆𝜆𝑂𝑂2𝐻𝐻𝐻𝐻− 𝜀𝜀𝜆𝜆𝐻𝐻𝐻𝐻�𝑂𝑂𝑂𝑂+ 𝜀𝜀𝜆𝜆𝐻𝐻𝐻𝐻�+2µ𝜆𝜆′ 𝑑𝑑��. 23 
To advance this model, van der Putten et al., incorporated a novel contrast-reduction parameter, 𝐾𝐾, into 21 
their multispectral oximetry algorithm. This parameter models the effects of tissue overlying a directly 22 
imaged vessel. 𝐾𝐾 is described as an arbitrary increase in greyscale intensity (𝐼𝐼𝑐𝑐), both in the centre of 23 
the vessel (𝐼𝐼𝑣𝑣) and outside the vessel (𝐼𝐼𝑜𝑜): 24 
 𝐾𝐾 = 𝐼𝐼𝑣𝑣+𝐼𝐼𝑐𝑐
𝐼𝐼𝑜𝑜+𝐼𝐼𝑐𝑐
 . 24 
Thus, transmission can be re-written as: 25 
 𝑇𝑇′λ = �𝐼𝐼𝑣𝑣+𝐼𝐼𝑐𝑐𝐼𝐼𝑜𝑜+𝐼𝐼𝑐𝑐�  = 𝑇𝑇λ(1 − 𝐾𝐾) + 𝐾𝐾. 25 
and the full optical transmission model can then be written as: 26 
 
𝑇𝑇′λ = �𝛼𝛼 10−�𝐶𝐶𝐻𝐻𝐻𝐻𝐻𝐻 𝑑𝑑��𝜀𝜀𝜆𝜆𝑂𝑂2𝐻𝐻𝐻𝐻−𝜀𝜀𝜆𝜆𝐻𝐻𝐻𝐻�𝑂𝑂𝑂𝑂+ 𝜀𝜀𝐻𝐻𝐻𝐻(𝜆𝜆)�+µ𝜆𝜆′ 𝑑𝑑�+ 𝛽𝛽10−�2𝐶𝐶𝐻𝐻𝐻𝐻𝐻𝐻 𝑑𝑑��𝜀𝜀𝜆𝜆𝑂𝑂2𝐻𝐻𝐻𝐻− 𝜀𝜀𝜆𝜆𝐻𝐻𝐻𝐻�𝑂𝑂𝑂𝑂+ 𝜀𝜀𝜆𝜆𝐻𝐻𝐻𝐻�+2µ𝜆𝜆′ 𝑑𝑑��  26 
                                                     
§ In simplistic terms, one can imagine the example of a straight-line fit, which requires at least two data points, 
from which two parameters – gradient and intercept – can be estimated.  
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(1 −𝐾𝐾) + 𝐾𝐾. 
To date, this is the most sophisticated multispectral oximetry algorithm developed and, without direct 1 
calibration, has provided plausible oximetry when utilised for in vivo experiments. For example, the OS 2 
of the spinal cord dorsal vein in rats was estimated to be 67.8 ± 10.4% at normoxia (mean ± SD, n = 3 
4),[7] and the OS of healthy blood vessels in murine tendons was estimated to be ~95%.[10] Despite 4 
these encouraging results, there are still numerous challenges associated with validation of multispectral 5 
oximetry algorithms. These are discussed extensively in the next section. 6 
Table 1. Summary of notable studies utilizing multispectral oximetry algorithms. 7 
Study Oximetry application Wavebands 
“Hard Wired” 
parameter values 
Estimated 
parameters 
recovered 
van der Putten 
et al. 2017.[7] 
Rat spinal cord 
dorsal vein 
546, 560, 570, 
584, 590, and 
600 nm 
ε, S. OS, c, S, d, K, 𝛼𝛼,𝛽𝛽. 
van der Putten 
et al. 
2017.[9,10] 
Mouse muscle 
tendon capillary 
 
410, 420, 430, 
435, 440, and 
450 nm 
ε, S. OS, c, S, d, K, 𝛼𝛼,𝛽𝛽. 
Hendargo et al., 
2015.[59] 
 
Mouse skin 
microvasculature 
540, 560, 580, 
and 610 nm ε. OS, c. 
Clancy et al. 
2015.[11] Porcine bowel 
440 – 700 nm, 
28 wavebands. ε. OS, c, S. 
Fernandes-
Ramos et al. 
2014.[5] 
Red blood cells 
(ex vivo) 
560 – 600 nm, 
8 wavebands ε. OS, c. 
Mordant et al. 
2014.[19] 
Retina( human 
glaucoma 
patients) 
556 – 650 nm 
47 wavebands ε, S. OS, c, d, 𝛼𝛼,𝛽𝛽. 
Chin et al. 
2012.[13] 
Diabetic foot 
ulcers in humans 
500 – 600 nm, 
15 wavebands ε. OS, c. 
Yudovsky et al. 
2011.[21] 
Diabetic foot 
ulcers in humans 
550 – 660 nm, 
15 wavebands ε, εmel. ΔOS, c, cmel, S. 
Mordant et al. 
2011.[60] Human retina 
500 – 650 nm 
300 wavebands. ε, S. OS, c, d, 𝛼𝛼,𝛽𝛽. 
Sorg et al. 2008. 
[4] and 2005.[3] 
Mouse tumor 
model 
505 – 575 nm, 
16 wavebands ε. OS, c, S, 𝛼𝛼,𝛽𝛽. 
Alabboud et al. 
2007.[61] Human retina 
500 – 700 nm 
27 + wavebands ε, S. OS, c, d, 𝛼𝛼,𝛽𝛽. 
Smith et al. 
2000.[62] Human retina 
488, 635, 670, 
752, 830 nm. ε. OS, c, S, d, 𝛼𝛼,𝛽𝛽. 
Drewes  et al. 
1999.[63] Human retina 
629, 678, 821, 
899 nm. ε. OS, c, S, d. 
 
Schweitzer et al. 
1999.[64] 
Human retina 510 – 586 nm, 76 wavebands ε, εmel. OS, c, d, 𝛼𝛼,𝛽𝛽. 
Key: ε = extinction coefficient of 𝐻𝐻𝑏𝑏 and 𝑂𝑂2𝐻𝐻𝑏𝑏 εmel = extinction coefficient of melanin pigmentation, S = 8 
scattering contribution; c = concentration of Hb, 𝛼𝛼,𝛽𝛽 = single and double pass contribution factors respectively; 9 
d = diameter of blood vessels; K = contrast reduction factor. 10 
2.4.2. Calibration and validation of multispectral oximetry algorithms  11 
 12 
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Potential errors in estimation of OS from MSI oximetry models, e.g. due to the influence of transmission 1 
quantification error or ill-defined/poorly-modelled systematic parameter(s), have not been thoroughly 2 
and robustly explored in the literature. In theory, the multi-parameter fit should minimise errors in OS 3 
due to error in transmission measurement at a single waveband, with robustness of fit increasing with 4 
the number of wavebands. Ideally, further research is required to quantify potential measurement errors. 5 
Like the work of Smith for two- and three-wavelength oximetry, such error minimisation research would 6 
likely take the form of simulations.[44] Direct experimental validation of MSI oximetry models, in 7 
absolute terms, remains a fundamental challenge in the field of oximetry. 8 
In the retina, (the vascular bed most commonly studied with oximetry) estimated OS can be compared 9 
to well-established reference values (e.g. 96% for arteries and 54% for veins).[40] However, in many 10 
other tissues, there are often no known absolute reference values for OS for the physiological context in 11 
which the MSI oximetry model is being applied. Further, blood vessels of interest are typically 12 
embedded in tissue that is both physiologically, and optically, complex; this complicates measurement 13 
and comparison. Further, in applications such as tumor development, OS is likely to be very different 14 
from established physiological norms due to abnormal metabolic demands.[3,4,22]  15 
Healthy control subjects can be used as a qualitative reference for comparison to diseased subjects, and 16 
to help infer inaccurate or spurious OS estimation. However, other factors such as anesthesia, local 17 
metabolic demand, inter-subject variability, and oxygen diffusion may affect blood flow rate and OS in 18 
healthy controls. Hence, it can  potentially be challenging to verify if perceived discrepancies in OS are 19 
due to artifacts introduced by a flawed MSI oximetry algorithm, or if they are actually due to real 20 
physiological variations.[59] 21 
In living subjects, pulse oximetry can only be used to only measure systemic arterial OS. Oxygen 22 
sensitive nanophosphors can be used to measure local partial pressure of oxygen, but such 23 
nanophosphors require biochemical expertise and complex phosphorescence lifetime imaging 24 
equipment; this presents a considerable barrier to entry for researchers (see Section 5.3.2 for more 25 
details).[65] Further, validation of in vivo multispectral oximetry algorithms by using artificial phantoms 26 
may not be possible due to the significant differences in optical properties between phantom construction 27 
materials (e.g. quartz or plastic capillaries) and real tissue (see Section 5.2 for more details on phantom 28 
design). Oxygen-sensitive interventions that induce changes in the OS of blood, do however, allow 29 
researchers to validate oximetry by inducing artificial changes in OS distinct from physiological norms, 30 
enabling inter-subject comparison. Such interventions are discussed in detail in Section 5.3.3.  31 
Fundamentally, the challenge of validating multispectral oximetry algorithms is that multispectral 32 
oximetry algorithms are often the only method capable of providing OS measurements in many 33 
physiological contexts, so no direct calibration with a “gold standard technique” is possible. Instead, the 34 
field has to rely on indirect qualitative validation provided by comparison to controls, and by OS –35 
altering interventions to provide context for multispectral oximetry results, and build a case for 36 
convincing oximetry measurements from context.  37 
3. Challenges for in vivo multispectral imaging oximetry  38 
3.1. Optical absorption by haemoglobin variants and blood plasma 39 
For understanding errors and uncertainties in oximetry, it is useful to consider the optical properties of 40 
blood constituents, other than haemoglobin (Hb), which may absorb or scatter light, and how these may 41 
alter the optical transmission of blood vessels. For example, variant globin proteins, blood plasma, and 42 
cells within blood. 43 
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Haemoglobin has two main variants, namely methemoglobin (MetHb), where the iron in heme groups 1 
is Fe3+ instead of Fe2+, and carboxyhemoglobin (CoHb), where carbon monoxide is bound to 2 
haemoglobin. If present in the blood, MetHb and CoHb can contribute spectral absorption that is similar 3 
to normal Hb.[66–68] However, the concentration MetHb and CoHb are normally present only at low 4 
concentration in blood and are thus generally ignored for oximetry.[68] Another molecule similar to Hb 5 
is neuroglobin, which supplies oxygen to nervous tissue, such as the brain and retina.[69] However, the 6 
extent to which neuroglobin can be found in the blood is currently unclear.[70–72] Other proteins similar 7 
to Hb can sometimes be found in the blood. For example, myoglobin (Mb) – a protein which supplies 8 
oxygen to muscle tissue - can be found in blood when a subject has undergone skeletal or cardiac muscle 9 
damage, e.g. due to a heart attack or traumatic injury.[73,74] The absorption spectra of Mb is broadly 10 
similar to Hb, but with weaker optical absorption because Mb contains only a single heme group 11 
compared to the four heme groups of Hb.[75] Mb is not considered in MSI oximetry, even in 12 
experiments that may cause muscle damage.  13 
White blood cells account for <1% of whole-blood volume, but do not contribute significant absorption 14 
or scattering,[76] and are not considered in oximetry. However, blood plasma is ~55% of the total 15 
volume of human blood, and contains many proteins which can absorb and scatter light.[77] When 16 
isolated from whole-blood, blood plasma has a pale-yellow coloration due to strong absorption by serum 17 
albumin at wavelengths < 550 nm. Additionally, blood plasma auto-fluoresces under ultraviolet and blue 18 
light exposure, [78] which could potentially induce errors in oximetry (see Section 3.4 for more on auto-19 
fluorescence). However, to the best of our knowledge, no oximetry studies to date have incorporated the 20 
optical parameters of blood plasma.  21 
3.2. Pigmentation within tissue  22 
Melanin is the main pigment chromophore** of concern for oximetry. Melanin strongly absorbs blue 23 
and green light, with red light less strongly absorbed.[79] If present in high concentration, absorption 24 
by melanin may be sufficient to make meaningful MSI oximetry challenging. Melanin is particularly 25 
abundant in the skin and retina, and as such, is particularly relevant for oximetry of blood vessels in 26 
these tissue beds. Retinal melanin can be quantified via the proxy of assessment of iris coloration; 27 
subjects with low retinal melanin tend to have blue iris coloration, whereas subjects with a high degree 28 
of retinal melanin tend to display brown iris coloration.[80]  29 
The non-uniform distribution of melanin in retinal tissues introduces considerable variability in the 30 
reflectivity of background for blood vessels, compromising oximetry measurements. For this reason, 31 
Hammer et al., (2008) introduced an empirically derived calibration factor to account for the effect of 32 
retinal melanin pigmentation in two-wavelength oximetry.[29] In subjects with minimal retinal melanin 33 
pigmentation, the retinal tissue is so transparent that the blood vessels of the choroid – at the back of the 34 
retina - can be directly studied by MSI oximetry.[14]  35 
Other chromophores such as adipose fat and yellow pigment could affect the spectra of tissue at visible 36 
wavebands, but the influence of such pigments is not normally accounted for in oximetry. Absorption 37 
by water is not typically a concern for oximetry, because water only strongly absorbs light at >1000 nm, 38 
which is beyond the waverange of 400 – 800 nm typically used for oximetry.  A thorough review on 39 
absorption and scattering properties of these miscellaneous tissue chromophores is provided by Jacques 40 
et al., (2013).[79] 41 
 42 
                                                     
** A chromophore is a molecule that absorbs visible light, responsible for the characteristic colour of a substance 
when viewed with the eye. 
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3.3. Optical scattering by tissue   1 
Optical scattering by tissue is due to inhomogeneities in the refractive index of the tissue, e.g. cells or 2 
blood vessel walls. Consequently, such scattering is well-described by Mie scattering theory, where the 3 
scattering structures are similar in dimension to the wavelength of light being scattered. Unlike Rayleigh 4 
scattering, Mie scattering does not strongly vary with wavelength, but becomes more important when 5 
absorption is reduced, e.g. at red and near-infra red wavelengths. The scattering properties of the 6 
skin,[81–83] the retina,[84,85] the sclera,[86] and blood[87] are well characterised.  7 
 8 
Optical scattering by overlying tissue can alter the transmission of blood vessels.[7] For example, in the 9 
tissue of the choroid, scattering results in blood vessel appearing to be brighter than the surrounding 10 
tissue, producing a negative OD. This is particularly apparent when the reflectivity of surrounding tissue 11 
is low. In such situations, two-wavelength oximetry calibration is not applicable, but nevertheless 12 
indications of relative OS may instead be reported in terms of ODR.[14] The best example of this 13 
phenomenon has been reported by Kristjansdottir et al., (2013).[14] 14 
Although generally unavoidable, scattering by skin tissue can be reduced by the application of optical 15 
clearing substances, which match the refractive index of inhomogeneities within tissue, thus reducing 16 
scattering. Optical clearing agents are typically used to reduce scattering in skin to provide deeper and 17 
clearer optical imaging, however, they may alter various tissue properties, andt mayrequire invasive 18 
injections for maximum effectiveness.[88,89] Hence, optical clearing agents are not commonly used in 19 
oximetry experiments. 20 
 21 
3.4. Other challenges of imaging through tissue  22 
Aside from absorption by chromophores and optical scattering, there are other challenges associated 23 
with imaging blood vessels through tissue, including limited depth penetration of light, tissue-specific 24 
wavelength filtering effects, polarization dependent effects, tissue geometry, and tissue auto-25 
fluorescence.  26 
 27 
The penetration depth of light in tissue is highly variable, with blue and green wavelengths generally 28 
limited to a penetration depth of < 2 mm due to strong absorption and scattering.[90,91] However, 29 
wavelengths between 600-1000 nm can pass further through tissue due to reduced absorption at these 30 
wavelengths, enabling applications such as pulse oximetry. This waveband is sometimes referred to as 31 
“the biological window”. Photoacoustic imaging techniques get around this limit by combining optical 32 
excitation with ultrasonic detection (see Section 6.4). 33 
 34 
Specific tissue may also have associated wavelength-filtering effects: for example, the lens within the 35 
human eye acts an ultraviolet filter, with the  transparency of the lens decreasing across all wavelengths 36 
with age.[92] Cataracts can also influence oximetry measurement by effectively applying a spectral-37 
filter function over images, consequently altering ODR of blood vessels imaged within the eye.[93,94]  38 
 39 
Tissues may also exhibit birefringence, caused by parallel strands of fibrous tissue. In the eye, the  sclera, 40 
the cornea, and the retinal nerve fibre layer are generally birefringent.[95–98] Birefringence is 41 
particularly important for studies utilising orthogonally polarised illumination to mitigate reflections 42 
(see Section 3.7) because birefringence can result in uneven tissue reflectivity that can cause challenges 43 
for oximetry. 44 
 45 
Defocus due to tissue curvature or bulk motion can significantly reduce the apparent contrast of blood 46 
vessels with respect to other features. Defocus due to tissue curvature is a particular challenge for both 47 
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endoscopic and ocular imaging. To minimise defocus, retinal oximetry studies typically limit 1 
measurements to a well-defined, well-constrained region near the optic disc[99]; when imaging the 2 
surface of the eye (the sclera), maximising the depth of field is a good strategy for minimising any 3 
potential defocus.[100] 4 
 5 
Some tissues may exhibit auto-fluorescence when illuminated with the appropriately exciting 6 
wavelengths (typically ultraviolet or blue light). For example, proteins within blood plasma will strongly 7 
auto-fluoresce under blue illumination (e.g. ~400 nm), and emit at longer wavelengths (e.g. ~500 8 
nm),[78] and auto-fluorescence of retinal tissue (excitation ~ 470 nm, emission at ~600 nm) is strong 9 
enough to be utilized as a retinal imaging modality in its own right.[101] To date, auto-fluorescence has 10 
not yet been considered as a source of potential errors in oximetry, but nevertheless it is prudent to be 11 
wary of, and minimise, any tissue auto-fluorescence in oximetry experiments. 12 
3.5. Scattering by blood   13 
3.5.1. General considerations 14 
Optical scattering by blood should be considered when interpreting transmission of blood vessels for 15 
oximetry. In blood, light is predominately Mie scattered by individual red blood cells (RBCs) which 16 
make up approximately 44% of total-blood-volume, and which are each ~6 – 8 µm in diameter with a 17 
concave shape (see Figure 4).[77] Proteins in blood plasma also contribute Rayleigh scattering effects, 18 
but the magnitude of this scattering is 100-1000 times less than scattering from RBCs.[77] The scattering 19 
properties of blood can alter due to several factors, including: changes in OS,[102] change in % of RBCs 20 
by volume (the haematocrit),[103] changes in overall blood volume (e.g. due to water drinking),[104] 21 
and changes in blood flow rate.[64,105]  22 
 23 
The quantitative parameters that describe the scattering of light by blood are the absorption coefficient 24 
( 𝜇𝜇𝑎𝑎) [units: cm-1M-1]; the scattering coefficient (𝜇𝜇𝑠𝑠) [units: cm-1]; the anisotropy factor (𝑙𝑙) 25 
[dimensionless]; and the effective scattering coefficient: 𝜇𝜇′𝑠𝑠  =  𝜇𝜇𝑠𝑠(1–  𝑙𝑙) [units: cm-1].[77] The 26 
anisotropy factor is defined as: 𝑙𝑙 = 𝑐𝑐𝑙𝑙𝑐𝑐(𝜃𝜃), where  𝜃𝜃 is the typical angle at which incident light is 27 
deflected by a scattering event. 𝑙𝑙 = 0 indicates no forward scattering, and 𝑙𝑙 = 1 indicates complete 28 
forward-scattering. For whole blood, 𝑙𝑙 has been estimated to be ~ 0.985 - 0.997, i.e. highly forward-29 
scattering.[57]  30 
 31 
 
Figure 4. Depiction of red 
blood cells showing their 
biconcave shape. Figure 
reproduced from the public 
domain.[106] 
3.5.2. The influence of oxygen saturation on optical scattering by blood  32 
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OS plays a role in determining the optical scattering properties of blood by mediating the transmission 1 
of blood. Monte Carlo simulations by Friebel et al., (2009) demonstrated that an increase in 𝜀𝜀𝜆𝜆 will 2 
decrease 𝑙𝑙. Thus, if a change in OS results in a decrease in the optical transmission of blood, then the 3 
degree of forward scattering through blood will also decrease, resulting in a further decrease in 4 
transmission, not described by the Beer-Lambert law.[102] 5 
3.5.3. The influence of blood flow speed on scattering and reflection by blood  6 
The orientation of RBCs within flowing blood is dependent on blood flow velocity: if blood is static or 7 
flowing very slowly, then RBCs will be randomly orientated, and biconcave in shape. However, if blood 8 
is flowing, then RBCs will preferentially align with the flow, and elongate in the direction of flow due 9 
to shear stress (see Figure 5).[107] This alignment consequently alters the optical properties of blood, 10 
particularly backscattering. Klose et al., (1972) demonstrated that preferential alignment of RBCs under 11 
flow results in an increase of backscattered light from blood vessels.[105] Schweitzer et al., (1999) 12 
demonstrated that once all RBCs are orientated in the same direction, then the back-scattered light would 13 
reach a maximum. For a 50 µM diameter blood vessel, this critical flow speed corresponding to complete 14 
preferential alignment was found, empirically, to be 6.4 mm/s.[64] Thus, it is important that blood flow 15 
speed is considered in oximetry experiments because blood at low, moderate, and critical flow rates will 16 
have different optical back-scattering properties. Back-scattering from blood can produce specular 17 
reflections, which can introduce errors into oximetry (see Section 3.6). 18 
 19 
 
Figure 5. Depiction of the preferential alignment of red blood cells under flow due to shear stress. 
Top: no flow. Bottom: under flow. A more detailed depictions of this phenomenon can be found in 
Cimalla et al., (2011).[107] Note, this depiction describes a relatively large blood vessel (e.g. 100- 
200 µm diameter), and is not valid in capillaries (<10 µm in diameter) were red blood cells 
elastically deform to flow through capillaries.[108] 
3.6. Mitigating specular reflections from blood vessels  20 
Illumination light can create a bright specular reflection from the surface of a blood vessel, typically 21 
manifesting in the centre of a vessel (see Figure 6). Such specular reflections can introduce errors in the 22 
estimation of transmission of a blood vessel and thus induce errors in MSI oximetry (see Figure 6). 23 
There are several methods for mitigating specular reflections. One strategy is to use off-axis illumination 24 
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of blood vessels, thus moving the position of specular reflections to a less intrusive angle. However, off-1 
axis illumination creates shadowing effects and is impractical for many in vivo applications, such as 2 
retinal imaging, where off-axis imaging requires invasive procedures.[109] Another, simpler, approach 3 
is to modify blood vessel transmission-measurement algorithms to compensate for reflections. With this 4 
approach, the potential for systematic errors should be carefully considered. Alternatively, annular 5 
illumination can be employed to back-illuminate blood vessels via diffuse scattering via surrounding 6 
tissue; totally eliminating specular reflection from the blood vessel.[110] 7 
Perhaps the most elegant approach to mitigate specular reflections is to use orthogonal polarization 8 
imaging (OPI). In OPI the illumination light is linearly polarised, but becomes depolarized when it 9 
undergoes multiple scattering by tissue. In contrast, specularly reflected light, does not lose its 10 
polarization because it does not undergo multiple scattering. Thus, by placing a linear polariser in the 11 
imaging path, with its polarization axis orientated orthogonally to the polarization axis of the 12 
illumination light, specular reflections can be completely mitigated, whilst light that has undergone 13 
multiple scattering by tissue is imaged.[111]  14 
 15 
 16 
 17 
 
Figure 6. An ideal blood vessel intensity-profile cross section, 
with and without specular reflection. Specular reflections 
increase the apparent intensity (Iv) in the centre of a blood 
vessel. 
3.7. Optical paths through blood vessels  18 
Light does not simply follow a single path through blood vessels; scattering, reflection, absorption all 19 
play a role in determining the path of individual photons through blood. Scattering is described in terms 20 
of scattering probabilities, with the outcome of each event determined in a pseudo-random manner. 21 
Hence, Monte Carlo simulations are a useful method for investigating light paths through blood vessels 22 
because they simulate many individual photons propagating through blood. Predictions by Monte Carlo 23 
models can be compared to experimental data to assess optical models or to test predictions of 24 
parameters, e.g. the scattering anisotropy factor of blood, g (see Section 3.5.1). 25 
Hammer et al., (2001) [112] used Monte Carlo simulations to investigate different light paths through 26 
blood vessels when the blood vessels were illuminated by retinal fundus cameras and scanning laser 27 
ophthalmoscopes (SLOs). Simulations were conducted for light in the waveband 520 -586 nm and 28 
investigated model blood vessels 25 – 200 µm in diameter. Examples of the light paths through blood 29 
vessels simulated in this study are shown in Figure 7. They found that back-scattered and single-pass 30 
transmitted light dominates for both fundus cameras and SLOs. However, compared to fundus cameras, 31 
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SLOs have a higher degree of backscattered light, with a relatively larger double pass transmission 1 
contribution.[112] 2 
Rodmell et al., (2014)[110] conducted Monte Carlo simulations to investigate if vessels can be diffusely 3 
illuminated by illuminating nearby tissue, instead of directly illuminating blood vessels, e.g. by using a 4 
confocal SLO illumination scheme. Their study concluded that if the tissue surrounding a vessel is 5 
illuminated, then the vessel will be effectively back-illuminated.[110] This finding has subsequently 6 
been used to simplify multispectral oximetry models by enabling the use of annular illumination to 7 
eliminate double-pass contributions in MSI oximetry models.[9,70] 8 
 9 
 10 
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Figure 7. Potential light paths through a blood vessel. (A) specular reflection. (B) backscattered. (C) 1 
double pass. (D) Single-pass (back illuminated).[112] 2 
3.8. Rattlesnake artefacts  3 
A common artefact in oximetry is “rattlesnaking”, where estimated OS spuriously varies along the 4 
length of a blood vessel, causing a stripey, “rattlesnake” pattern to appear when OS is visualized as a 5 
colour-coded map (see Figure 8). Spurious variations in estimated blood vessel transmission can arise 6 
due to a number of reasons, including variations in red blood cell concentration, optical scattering, 7 
background pigmentation, and vessel-fitting errors. To minimize the adverse effects of rattlesnaking, 8 
OS is often averaged along the length of a blood vessel or vessel segment to reduce random variations 9 
in OS prior to further analysis. 10 
 11 
Figure 8. Two-wavelength retinal oximetry images of a healthy subject (left) and a subject with chronic 12 
obstructive pulmonary disorder (right). Rattlesnaking artefacts are apparent in both subjects. Figure 13 
reproduced from Eliasdottir et al., (2017) under a Creative Commons BY 4.0 licence.[113] 14 
3.9. Oxygen diffusion  15 
 16 
Oxygen diffusion has recently emerged as both a challenge and a tool for oximetry of blood vessels 17 
exposed to ambient air, e.g. in bulbar conjunctival and tendon oximetry.[10,15] Oxygen will naturally 18 
move from regions of high partial pressure of oxygen (pO2) (e.g. the air) to areas of lower pO2 (e.g. 19 
exposed blood vessels), until a pO2 equilibrium is reached. This will raise the OS of blood. Nominal pO2 20 
of blood is ~ 100 mmHg and ~ 40 mmHg for arteries and veins respectively, whereas nominal pO2 of 21 
air at sea level is much higher, at ~160 mmHg.[27] Therefore, if blood reaches equilibrium with ambient 22 
air, then the OS of blood will be close to 100%. The rate of oxygen diffusion for air to blood is described 23 
by Fick’s law of diffusion, which incorporates two main factors: the pO2 gradient, and the oxygen 24 
diffusivity of any tissue between the air and the blood. The oxygen diffusivity of tissues depends on 25 
tissue thickness and composition.[114–117] 26 
Oxygen diffusion will occur when blood vessels are exposed to the ambient air. Foe example. in the first 27 
MSI oximetry study of the bulbar conjunctival microvasculature (located on the surface of the eye), 28 
MacKenzie et al., (2016)[15] observed rapid oxygen diffusion from ambient air into hypoxic bulbar 29 
conjunctival microvessels when the eyelid was open. This oxygen diffusion occurred in a timescale of 30 
just a few seconds, with 50% of the oxygen diffusion occurring on average in 3.4 ± 1.4 seconds (see 31 
Figure 10). Closure of the eyelid created a barrier to oxygen diffusion from ambient air. Due to this 32 
oxygen diffusion, it is thought that all bulbar conjunctival vessels will be highly oxygenated when 33 
exposed to air after a few seconds.[15]  34 
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This diffusion oxygenation effect has been exploited by other studies. Sarkar et al., (2017) exploited 1 
oxygen diffusion to remove OS as a source of uncertainty in their experiments to non-invasively measure 2 
bulbar conjunctival haemoglobin concentration for anemia diagnosis.[118] van der Putten et al., 3 
(2017)[9] utilized reoxygenation by diffusion as an intervention to alter OS and confirm oximetry 4 
capability.[9] It has been suggested that oxygen diffusion rates could be investigated as a parameter for 5 
the measurement of microvascular function, e.g. to investigate vessel wall thickening due to diabetes, 6 
but further research on this matter is required.[15]  7 
Oxygen diffusion is a concern in studies where blood vessels are surgically exposed, because oxygen 8 
diffusion can spuriously increase blood OS. A test for ongoing oxygen diffusion into surgically exposed 9 
venules was reported by van der Putten et al., (2017)[7] They reasoned that if oxygen diffusion was 10 
occurring, then blood would become more oxygenated as it flowed down the length of a vein. In their 11 
particular case, van der Putten et al. did not observe an OS gradient along the length of veins examined. 12 
indicating no significant oxygen diffusion into these veins.[7] 13 
In the retina, oxygen diffusion is not a concern, because retinal blood vessels are shielded from air by 14 
the tissue of the eye. However, the potential effects of oxygen diffusion should be carefully considered 15 
in any oximetry application where blood vessels may be exposed to air. For example, if invasive 16 
intravitreal retinal illumination is used, then diffusion may cause spurious changes in OS.[109] 17 
 18 
Figure 9. Oxygen diffusion from ambient air causes rapid reoxygenation of hypoxic 19 
bulbar conjunctival blood vessels (blue line). The ODR of episcleral vessels (red line) 20 
and fingertip pulse oximeter OS (green line) remain constant because these blood vessel 21 
beds are embedded within tissue and thus do not undergo diffusion. The x-axis is 22 
elapsed time after the subject opens their eyelid. Error bars represent the standard error 23 
of the mean. For clarity, pulse oximetry error bars of ± 2% OS are not shown. NB: in 24 
this diagram SO2 denotes OS. Figure reproduced from MacKenzie et al., 2016 with 25 
permission.[15] 26 
3.10. Multi-OS laminar flow in trunk veins 27 
 28 
It is common for multiple tributary venules to merge into a single larger, trunk vein. This results in 29 
multiple non-mixing, laminar, blood streams of varying OS flowing within trunk veins, producing a 30 
heterogeneous OS distribution. This will introduce errors into the estimation of OS, because all oximetry 31 
algorithms to-date assume a single homogenous OS across the breadth of a vessel.  32 
 33 
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This multi-OS laminar flow phenomenon is most readily observed during retinal fluorescein 1 
angiography, but can also be verified with flow-sensitive optical coherence tomography,[119] and 2 
multispectral imaging.[59] Hendargo et al., (2015) have provided the clearest demonstration of the 3 
multi-OS laminar flow problem.[59] However, at the time of writing, no method to estimate and/or 4 
compensate for the error due to this multi-OS laminar flow has been developed. 5 
 6 
4. Image processing for multispectral imaging oximetry   7 
4.1. Image acquisition 8 
Image acquisition for multispectral imaging generally follows best practice for general scientific 9 
imaging in that images should be well-exposed so as to have a good signal to noise ratio, dark current 10 
and random noise in the detector should be accounted for, and images should be acquired at the highest 11 
possible bit-depth to ensure maximum sensitivity to changes in intensity across the scene. Additionally, 12 
images should be saved in uncompressed format (e.g. .TIFF), because saving images in a compressed 13 
format (e.g. .jpg) can result in artefacts (see Figure 10).  14 
Sensitive monochromatic scientific detectors (e.g. CCDs and CMOS detectors) are best suited for MSI 15 
oximetry due to their low noise levels, high sensitivity, fast read out rates, and generally good hardware 16 
to control software connectivity. Some oximetry studies have utilized consumer single lens reflex (SLR) 17 
cameras as detectors, although good software control and high data acquisition rates are typically harder 18 
to achieve compared to scientific detectors.[7] 19 
 20 
Figure 10. The scene in sub-figure A was acquired simultaneously in 21 
two image formats: RAW (uncompressed) and .jpg fine (compressed). 22 
The yellow line indicates the line-profile selected for analysis. (B) The 23 
corresponding intensity line-profile can be seen to differ between 24 
formats, with the .jpg image showing increased apparent intensity at the 25 
centre of the line profile. If this line profile were of a blood vessel, these 26 
.jpg compression artefacts would result in a different estimation of 27 
blood vessel transmission, and thus introduce systemic errors in the 28 
estimation of OS. 29 
4.2. Co-registration of multispectral images 30 
Prior to MSI oximetry analysis, co-registration of multispectral images is essential to ensure that the 31 
same region of a blood vessel is analyzed in each image at a different waveband. Broadly speaking, 32 
there are two main classes of multispectral image co-registration algorithms: feature-matching co-33 
registration and cross-correlation co-registration. 34 
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4.2.1. Feature-matching co-registration algorithms  1 
Feature-matching algorithms are best applied to co-registration of “feature-rich” images: i.e. images 2 
with features that exhibit strong contrast and distinct boundaries. In brief, feature-matching algorithms 3 
detect distinct features in different images, determine which points corresponds to detected points in 4 
other images, estimate the relative displacement of these matching points, and then compute a 5 
corresponding affine transform to apply operations such as rotation, scaling, shear, and reflection; 6 
resulting in co-registration of the two images (see Figure 11). Affine transforms are defined as 7 
transforms that preserve linearity of features, along with the ratio of distances.[120] 8 
For feature-matching co-registration algorithms to perform well, a large number of potential registration 9 
points must be used, requiring numerous distinct features. However, automatically identifying enough 10 
distinct features can be highly challenging in biological imaging. For example, feature-matching 11 
algorithms can struggle to detect blood vessels across different wavebands, because the contrast of blood 12 
vessels compared to background tissue varies greatly between green and red wavebands (see Figure 12). 13 
 14 
 
Figure 11.  Principle of a feature-matching image co-registration 
algorithm. (A) Main image. (B) Arbitrarily displaced image. (C) Distinct 
unique features identified are identified.. (D) Matching distinct and 
unique features are identified in image B, and used to compute an image 
transform to co-register images A and B. 
 15 
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Figure 12. Retinal images of two different subjects 
at 577 nm and 600 nm. Top: a subject with a low 
degree of retinal pigmentation. Bottom: a subject 
with a high degree of retinal pigmentation. The 
bright white region is the optic disk. 
4.2.2. Cross-correlation co-registration algorithms  1 
Unlike feature-matching algorithms, cross-correlation image co-registration algorithms can be applied 2 
to images with poor feature contrast. However, this comes with the requirement of considerably more 3 
computational processing time than feature-matching algorithms. Cross-correlation-based registration 4 
algorithms work by overlaying two images and calculating the cross-correlation function of the two 5 
images, which can be calculated rapidly by fast Fourier transform techniques. The algorithm will then 6 
iteratively apply incremental transforms in one of the images, checking the cross-correlation function 7 
after each iteration, until a global maximum is reached. However, reaching a global maximum can 8 
require many iterations of image transformation, and thus can be computationally time-9 
intensive.[61,121] A logic flow-chart for a cross-correlation algorithm is shown in Figure 13. 10 
 11 
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Figure 13. An exemplar logic flow-chart for a cross-correlation image 
co-registration algorithm. Rectangular nodes represent operations. 
Diamond nodes represent decision points. 
 1 
4.2.3. Other challenges of in vivo image registration  2 
Automatic image registration algorithms rely on the assumption that features in the scene are 3 
unchanging. This assumption is not always true, especially when using time-sequential MSI in vivo. For 4 
example, subject motion can introduce motion blur or defocus,[122] and conjunctival blood vessels are 5 
semi-mobile relative to background tissue.[15] In such challenging circumstances, semi-automatic 6 
registration using human input may be required to successfully identify features for successful co-7 
registration.[123] 8 
4.3. Estimating the transmission of blood vessels  9 
Estimation of the transmission of a blood vessel requires the measurement of three parameters:  10 
1. The intensity of light at the centre of the blood vessel (Iv) 11 
2. The intensity of light in the position corresponding to the centre of the blood vessel, if the 12 
blood vessel were not present (Io). 13 
3. The diameter of the blood vessel. 14 
The typical approach to estimate these parameters is to analyse an intensity line profile across the blood 15 
vessel and nearby tissue, orthogonal to the direction of blood flow. The length of the line profile is 16 
arbitrary, but as a rule of thumb, a line profile length equivalent to three times the blood vessel diameter 17 
should suffice. Fischer et al., (2010) [124] proposed an algorithm to estimate the blood vessel diameter 18 
by defining the blood vessel walls as being the points in a line profile corresponding to greatest rate of 19 
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change of intensity.[124] . Iv is typically estimated by fitting a function such as a Gaussian or parabola 1 
to the inside of a blood vessel, and recovering the intensity at the centre of the vessel. Io is typically 2 
estimated by plotting a linear fit to the surrounding tissue and extrapolating this linear fit to find the 3 
intensity at the position corresponding to the centre of the vessel. Figure 15 shows an example of a line 4 
profile fitting scheme. Further examples of line profile fitting with real line profiles can be found in van 5 
der Putten et al (2017).[5] 6 
 7 
 
Figure 14. Depiction of a vessel profile fitting 
scheme to estimate vessel diameter, and intensity 
inside the vessel (Iv) and the background intensity if 
the vessel were not present (Io). Reproduced with 
permission from MacKenzie et al., (2016).[15] 
5. Strategies for validation of multispectral imaging oximetry  8 
For many applications, MSI oximetry is the only oximetry technique capable of measuring OS in the 9 
blood vessels under investigation; no “gold standard” reference technique is available. Instead, MSI 10 
oximetry has to rely on somewhat indirect methods of validation. This section describes the various 11 
techniques which have been employed to validate oximetry and related assumptions. 12 
  13 
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5.1. Testing fundamental optical assumptions: Monte Carlo Simulations 1 
MSI oximetry algorithms incorporate multiple optical parameters to estimate changes in blood vessel 2 
transmission due to OS (see Section 2.4). Some parameters, such as the extinction coefficient of 3 
chromophores, can be “hard-coded” from empirically measured values. However, other parameters, 4 
such as the degree of single pass and double pass light path contributions are challenging to estimate 5 
from experiments. Computational Monte Carlo simulations have been utilized as a method for testing 6 
and validation of optical assumptions which would otherwise be highly challenging or not possible to 7 
experimentally verify. However, Monte Carlo simulations have some drawbacks, mainly the expertise 8 
and expense associated with using computational simulation software. Additionally, researchers must 9 
be sure that the simulation software incorporates all relevant biological and optical parameters (e.g. 10 
tissue scattering functions) that are required for comprehensive optical simulation. For examples of how 11 
Monte Carlo simulations have been used to test assumptions in oximetry, refer to Sections 3.5.2 and 3.7.  12 
5.2. Validation with artificial phantoms 13 
Phantoms are artificial constructs designed to mimic blood vessels and tissue, for the purpose of testing 14 
oximetry measurements in “well controlled”†† scenarios. Phantoms typically incorporate ex vivo blood, 15 
with OS of that blood controlled by one of three methods: (1) bubbling oxygen-free gas through blood 16 
(e.g. Nitrogen or Argon) [125,126]; (2) by addition of a chemical such as sodium dithionite [46] or 17 
sodium bicarbonate [127]; or (3) by introducing an oxygen consuming micro-organism, such as yeast, 18 
to the blood.[128] OS of ex vivo blood can be verified by an ex vivo blood gas analyzer or partial pressure 19 
of oxygen probe, giving a useful comparison point for MSI oximetry.  20 
The design and construction of phantoms for MSI oximetry varies considerably depending on the tissue 21 
being simulated and MSI modality. For example, a retinal oximetry phantom may consist of blood-filled 22 
capillaries within a water-filled model eye,[129] whereas a photoacoustic imaging phantom may consist 23 
of a thick gelatinous agar slab with blood-filled capillaries embedded within. Phantoms can also contain 24 
embedded test-targets to verify imaging performance.[130] Complex flow-cells designed to mimic the 25 
microcirculation in both flow speed and oxygen extraction have also been fabricated.[126] A full review 26 
of MSI phantoms across all modalities is beyond the scope of this tutorial, but a summary of phantoms 27 
for MSI oximetry in the eye can be found in Mackenzie et al., (2017).[6] 28 
5.3. In vivo validation strategies  29 
5.3.1. Blood gas measurement and pulse oximetry 30 
Blood gas analysis of ex vivo blood samples from large blood vessels (e.g. the antecubital vein) was the 31 
first technique used to validate in vivo retinal oximetry.[32] However, direct blood sampling is now 32 
rarely done due to several reasons: 1. Invasive procedures that cause a risk of harm to a subject should 33 
be avoided wherever possible [131];‡‡ 2. Suitably qualified staff are required to draw blood from a 34 
human subject; 3. Pulse oximetry has provided a quick, convenient, and non-invasive alternative in 35 
humans (as well as other animals); and 4. a standardized set of reference OS values has been adopted 36 
for two-wavelength retinal oximetry.[40] However, ex vivo blood gas measurement may be used in 37 
animal studies, where animal handling is done exclusively by suitably-trained and suitably-licensed 38 
individuals.[132] 39 
                                                     
†† Blood behaves quite differently in vivo and ex vivo; effects such as RBC aggregation are apparent in ex vivo 
blood but not in vivo blood. As such, phantoms utilising ex vivo blood are not necessarily “well controlled” in the 
traditional sense, but such phantoms do offer researchers control over key variables, e.g. OS, to a degree not 
possible in in vivo experiments. 
‡‡ Medical research involving human subjects must be carried out in accordance with the tenants of The 
Declaration of Helsinki, as set out by the World Medical Association.[131] 
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In humans, pulse oximetry can be applied to the fingertip and earlobe, whereas paw and carotid artery 1 
pulse oximeters are available for small animals. However, calibrating two-wavelength oximetry to 2 
arterial OS alone, leads to systematic errors in estimating venous OS (see Section 2.1.3 for more details). 3 
5.3.2. Oxygen sensitive nanophosphors and dyes 4 
The pO2 within blood can be non-invasively verified by imaging of nanophosphor probes with pO2-5 
dependent optical emission properties. In brief, nanophosphors refer to a class  of nanoscale 6 
phosphorescent biochemical probes that emit light and which are bound to a carrier protein, e.g. serum 7 
albumin. These nanophosphors typically require ultraviolet or blue excitation, which severely limits the 8 
depth to which they can be imaged within tissue, and which can induce photo-toxicity and tissue auto-9 
fluorescence.[133] Additionally, for robust measurement, these nanophosphors require complex 10 
phosphorescence lifetime imaging equipment. The combination of these factors mean that 11 
nanophosphor oxygen probes are not widely used for oximetry verification. Dmitriev et al., (2012) 12 
provide a review of the oxygen-sensitive nanophosphors available, along with associated 13 
challenges.[133] Shonat et al., (1997) is a good example of verifying MSI oximetry with 14 
nanophosphors.[65] 15 
5.3.3. Physiological interventions that alter oxygen saturation  16 
Physiological interventions such as systemic hyperoxia, systemic hypoxia, oxygen diffusion, and retinal 17 
flicker light stimulation enable researchers to induce artificial changes in OS, distinct from physiological 18 
norms. This enables researchers to verify oximetry capability and test physiological responses to 19 
stimuli.[6,7,134]  20 
In hyperoxia interventions, excess oxygen is administered to a subject, increasing systemic OS. Arterial 21 
OS is increased from ~95-97% to 100%, and venous OS increases by a larger margin. Temporary 22 
hyperoxia is thought to be a safer intervention than temporary hypoxia for subjects with cardiovascular 23 
impairment, although long-term hyperoxia itself can be damaging.[1] A particularly effective use of a 24 
temporary hyperoxia intervention was by Kristjansdottir et al., (2013). Their study used hyperoxia to 25 
demonstrate that choroidal vessels, even veins, are normally highly oxygenated.[14] Without a 26 
hyperoxia intervention, this insight would not have been possible.[6] 27 
In hypoxia interventions, air with reduced oxygen content is administered to a subject, decreasing both 28 
arterial and venous OS. Hypoxia is often associated with autoregulation vessel dilation that increases 29 
flow rate to maintain oxygen consumption.[28] Hypoxia interventions have led to insights that would 30 
otherwise not be possible, for example, MacKenzie et al., (2016)[15] utilised a hypoxia intervention to 31 
decrease OS and consequently observed rapid oxygen diffusion from air into bulbar conjunctival 32 
microvasculature.[15]  33 
Deliberate introduction of oxygen diffusion itself has recently emerged as a new intervention technique 34 
for oximetry. MacKenzie et al., (2016) utilised eyelid closure to control oxygen diffusion to bulbar 35 
conjunctival vessels,[135] and van der Putten et al., (2017) surgically exposed blood vessels to air to 36 
increase OS via diffusion; they blocked diffusion by using oxygen-impermiable plastic film. This 37 
control of diffusion  helped van der Putten et al. verify the oximetry measurement capability of their 38 
system, and confirmed low initial OS in the blood vessels studied.[10] 39 
In the retinal oximetry studies, flickering light illumination can be used to alter the metabolic demand 40 
of retinal tissue, and thus change uptake of oxygen by blood, altering OS. Unlike hyperoxia and hypoxia, 41 
flicker light stimulation does not change systemic OS.[6] 42 
6. Multispectral oximetry imaging modalities  43 
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6.1. Time-sequential multispectral imaging 1 
Conventional broadband imaging systems (e.g. retinal fundus cameras, microscopes, and endoscopes) 2 
can be adapted for MSI by spectrally filtering light prior to detection. There are two basic approaches 3 
to MSI oximetry: time-sequential MSI and snapshot MSI.  4 
In time-sequential imaging, images at various wavebands are acquired sequentially by switching spectral 5 
filters in either the illumination or detection path. Time-sequential filtering technologies include 6 
mechanically switched bandpass interference filters, liquid crystal tunable filters (LCTFs), and acousto-7 
optical tunable filters (AOTFs) (see Table 2 for a comparison of these technologies).[136] In addition, 8 
laser-based imaging techniques such as scanning laser ophthalmoscopes and photoacoustic techniques 9 
rely on time-sequential switching of laser illumination for spectral discrimination. 10 
Time-sequential MSI are poorly suited for observation of rapid biological processes which occur in the 11 
timescale of milliseconds (e.g. oxygen diffusion). For observing such rapid events, snapshot MSI is 12 
preferable.[59] 13 
 14 
Table 2. Comparison of electronically switchable optical filter technologies. 15 
Filter type Technology type Switching time 
Spectral 
Bandwidth 
Filter operation area and 
limitations 
LCTFs Layered liquid crystal filters. ~50 ms ~ 10 nm. 
 
Large beam area (e.g. a 25 mm 
diameter aperture); polarization 
dependent filtering.[136] 
AOTFs 
Radio-frequency 
acoustic pressure wave 
modulated crystal 
transmission filter. 
~ 25 µs ~ 2 nm. 
Small beam area (e.g. a 
diameter of a few mm); 
requires well collimated 
light.[136]  
Bandpass 
filters 
Filters on a motor-
controlled switching 
mount. 
~1 s 
Typically ~ 10 
nm, but highly 
variable. 
Large beam area 
(e.g. 25 mm diameter aperture). 
6.2. Snapshot multispectral imaging 16 
Snapshot MSI technologies enable simultaneous acquisition of images at multiple spectral wavebands 17 
reducing oximetry artefacts,[59] and providing sub-second temporal resolution.[5]§§ A variety of 18 
snapshot MSI imaging systems have been produced,[137–141] but only two approaches have found 19 
substantial usage in oximetry: beam-splitter multiplexing and the  Image Replicating Imaging 20 
Spectrometer (IRIS). 21 
Beam splitter multiplexing is the simplest form of MSI and has been incorporated into several retinal 22 
oximetry systems.[16,39,40] In such systems, a broadband image is split into two or more paths by one 23 
or more beam splitters, producing a cascade of images which can be individually spectrally filtered. 24 
                                                     
§§NB: an alternative MSI approach is to scan a point or line across a field of view, acquiring a spectral dataset 
via a spectrometer of the point “in a hyperspectral snapshot”, i.e. the reflectance spectrum from that single 
point.[38,160] However, this approach doesn’t enable image co-registration to account to subject motion, and 
hasn’t been widely applied for MSI oximetry. 
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However, this approach becomes increasingly optically inefficient with the addition of more beam 1 
splitters.[59]  2 
The IRIS operates by employing a combination of wave plates and Wollaston prisms to spectrally de-3 
multiplex a broadband image in multiple images of distinct wavebands. IRIS systems can be tailored for 4 
specific applications, including oximetry.[142–144] IRIS has been utilized for measuring rapid oxygen 5 
release from red blood cells as well as observing fast oxygen diffusion into blood vessels.[5,15,28]  6 
6.3. Scanning laser ophthalmoscopes 7 
Scanning laser ophthalmoscopes (SLOs) utilize laser raster scanning to image the retinal reflectance for 8 
MSI oximetry. Compared to conventional retinal fundus cameras, SLOs can provide advantages in 9 
spatial resolution, contrast, and imaging field-of-view on the retina. Adaptive optics MSI SLOs have 10 
been developed to compensate for involuntary eye movement and thus enable imaging of the small 11 
retinal vessels.[145] Additionally, SLOs can be used in situations where retinal oximetry with a 12 
multispectral fundus camera would be challenging, such as imaging the retina of infants.[146] However, 13 
oximetry with MSI SLOs is fundamentally limited by the laser wavelengths available, resulting in sub-14 
optimal wavelength combinations for oximetry.[147]  15 
6.4. Photoacoustic imaging 16 
 17 
Since the mid-2000s, photoacoustic imaging techniques*** have emerged as a powerful family of MSI 18 
imaging technologies that combine the advantages of optical absorbance contrast with the advantages 19 
of ultrasonic detection. Due to this unique combination of properties, photoacoustic techniques can 20 
provide deep-tissue maps of blood OS without the surrounding tissue.  In photoacoustic techniques, a 21 
high intensity laser pulse (< 10 ns duration) is incident upon blood. This pulse is absorbed, and the blood 22 
heats up, resulting in rapid expansion and contraction of the blood. This expansion and contraction 23 
generates ultrasonic pressure waves, which are detected by one or more ultrasound transceivers. The 24 
amplitude of ultrasound generated by the blood is directly proportional to how much light was absorbed 25 
by the blood at the illuminating wavelength. Thus, the ratio of ultrasound amplitudes at two or more 26 
wavelengths can then be related to OS.  27 
Broadly speaking, there are two variants of photoacoustic imaging:  Photoacoustic Tomography (PAT), 28 
and Photoacoustic Microscopy (PAM), which offer different capabilities in terms of tissue depth 29 
penetration and spatial resolution. 30 
In PAT, tissue is diffusely illuminated with a laser pulse, and the resulting ultrasound signal is detected 31 
and reconstructed by computational back-projection algorithms means to form a 3D optical absorption 32 
distribution. When imaged at multiple wavelengths, this absorption can then be related to OS in a manner 33 
similar toconventional oximetry theory (e.g. two-wavelength oximetry). PAT can image blood vessels 34 
embedded within several centimeters of tissue with a spatial resolution of ~ 10 – 100 µm.[148] Due to 35 
this capability, PAT is particularly advantageous for deep tissue applications such as whole body small 36 
animal imaging, brain imaging, and tumor imaging.  37 
PAM provides higher spatial resolution, but at the expense of imaging depth. In PAM, an image is built 38 
up by raster scanning a dual-focused optical beam and ultrasound detector across a target. The spatial 39 
resolution of PAM is determined by the convolution of the PSF of optical spot and ultrasound detector; 40 
therefore, higher resolution images require higher frequency ultrasound detectors, which greatly reduces 41 
depth penetration through tissue.  Lateral spatial resolution of ~1 µm has been achieved with PAM, 42 
limited to a depth of ~ 100 µm in tissue.[149,150]  43 
                                                     
*** also known as optoacoustic imaging. 
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Despite the impressive capabilities of PAT and PAM, these techniques require complex and expensive 1 
equipment, acoustically-coupled detection, and intense laser illumination. This makes photoacoustic 2 
techniques unsuitable for retinal imaging in humans. Further, increasing the temporal resolution of 3 
photoacoustic techniques is highly challenging.[151] These drawbacks present a considerable barrier of 4 
entry for new researchers to the field. Consequently, photoacoustic techniques are very powerful, but 5 
are not yet as widely applied to oximetry as time-sequential or snapshot MSI techniques. 6 
6.5. Spectroscopic Optical Coherence Tomography  7 
 8 
Spectroscopic Optical Coherence Tomography (S-OCT) is a variant of Optical Coherence Tomography 9 
(OCT) where the spectral absorbance of blood is inferred from the light back-scattered from blood 10 
vessels. S-OCT is a point scanning technique, which is spectrally snapshot, but spatially time-sequential 11 
because the image is built-up from a raster-scanned spot. S-OCT enables 3D maps of OS combined with 12 
3D mapping of tissue structure. This capability can be used to create 3D maps of tissue features such as 13 
blood vessel wall thickness,[152] however, all OCT techniques suffer from shadowing from overlying 14 
tissue and blood vessels. S-OCT has been in development since the mid-2000s and has mainly been 15 
applied to retinal and brain imaging in animals due to illumination intensity limitations.[153] However, 16 
S-OCT oximetry in humans was recently demonstrated for the first time: an important and highly 17 
promising milestone.[42,154] 18 
6.6. Dual-wavelength photothermal optical coherence tomography  19 
Dual-Wavelength Photothermal Optical Coherence Tomography (DWPT-OCT), like photoacoustic 20 
techniques, is based upon heating of blood by light. In DWPT-OCT, light incident upon a blood vessel 21 
is absorbed by blood, and heats the blood, producing small thermal perturbations (in the order of 22 
nanometers) proportional to the absorption coefficient of blood, and thus proportional to OS. The very 23 
small thermal perturbations are then measured by phase-sensitive optical coherence tomography.[155] 24 
However, to-date DWPT-OCT has been only utilized for oximetry in phantoms and the brain of 25 
anesthetized mice.[156–158]  26 
7. Summary and Conclusions  27 
The tutorial article is designed to serve as a broad introduction to MSI oximetry, whilst still also 28 
providing detailed content for the more experienced researcher. This article covers the optical theory of 29 
MSI oximetry, discusses the various MSI oximetry imaging modalities, and describes the many 30 
challenges encountered when applying MSI oximetry to in vivo application. 31 
For decades, two-wavelength oximetry has been the most widely applied oximetry imaging technique. 32 
However, multispectral oximetry algorithms techniques have demonstrated considerable promise for the 33 
myriad and diverse applications where reliable reference OS values are not yet known, pushing the 34 
boundaries of the field of oximetry. Nevertheless, calibration and verification of all oximetry techniques 35 
remains a fundamental challenge.  36 
Imaging modalities for MSI oximetry are rapidly progressing, with several powerful new imaging 37 
modalities emerging and providing capabilities beyond standard imaging techniques. Snapshot MSI 38 
technology provides sub-second oximetry capability, providing the ability to observed rapid biological 39 
processes such as microvascular oxygen diffusion and oxygen release from RBCs. Photoacoustic and 40 
endoscopic techniques provide deep-tissue oximetry measurement capability, particularly useful in 41 
applications such as the study of tumour development and rheumatoid arthritis. S-OCT is maturing as a 42 
viable technique for combined retinal oximetry and retinal tissue structure mapping in the human eye. 43 
Further, access to powerful computational processing techniques has enabled automatic oximetry 44 
analysis in a clinical setting.  45 
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In addition to developments of MSI oximetry techniques, new OS-altering physiological interventions, 1 
have emerged. These interventions, such as temporary hyperoxia, temporary hypoxia, controlled oxygen 2 
diffusion, and retinal flicker-light stimulation, have proven to be a powerful tool for researchers to assess 3 
oximetry capability, and explore physiological norms and responses. 4 
Historically, advances in oximetry technology have led to new insights into physiological norms and 5 
disease development. Given the recent pace of developments in the field of MSI oximetry, it is not 6 
unreasonable to expect further developments in the understanding of physiology and disease in the 7 
future.  8 
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